5 new clinical trials for TNBC, HER2 positive, and other subtypes of stage IV breast cancer (stage 4) have been added to BreastCancerTrials.org (BCT) in the last month. These clinical trials can also be found on Metastatic Trial Search (MTS).
Stage IV Triple Negative Breast Cancer
Stage IV HR Positive (HR+) Breast Cancer
- Chemotherapy Plus One or Two Immunotherapies for Women With Advanced ER Positive, HER2 Negative Breast Cancer
- Fulvestrant With or Without Capivasertib In Advanced ER Positive, HER2 Negative Breast Cancer
- Fulvestrant & Abemaciclib With and Without Copanlisib in Metastatic Hormone Positive, HER2 Negative Breast Cancer
Stage IV HER2 Positive Breast Cancer
Last Modified on July 24, 2020